|
Real-time Estimate
Cboe BZX
14:31:15 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 3.665 USD | -0.95% |
|
-5.67% | -2.14% |
| 08-18 | SAB Biotherapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | SAB Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 337M 290M 274M 249M 466M 31.8B 469M 3.24B 1.26B 16.26B 1.26B 1.24B 53.41B | P/E 2026 * |
-3.6x | P/E 2027 * | -4.78x |
|---|---|---|---|---|---|
| Enterprise Value | 81.92M 70.68M 66.58M 60.66M 113M 7.74B 114M 788M 306M 3.96B 308M 301M 13B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 958x |
| Free-Float |
99.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : SAB Biotherapeutics, Inc.
| 1 day | -0.95% | ||
| 1 week | -5.67% | ||
| Current month | -1.35% | ||
| 1 month | -3.43% | ||
| 3 months | +5.17% | ||
| 6 months | -10.07% | ||
| Current year | -2.14% |
| 1 week | 3.6 |  | 3.99 |
| 1 month | 3.5 | | 3.99 |
| Current year | 3.28 | | 5.15 |
| 1 year | 1.85 | | 5.15 |
| 3 years | 1 | | 10.5 |
| 5 years | 1 | | 129 |
| 10 years | 1 | | 129 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eddie Sullivan
CEO | Chief Executive Officer | 60 | 2014-06-30 |
Samuel Reich
CEO | Chief Executive Officer | 51 | 2024-02-01 |
Lucy To
DFI | Director of Finance/CFO | 40 | 2024-08-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Jay Skyler
BRD | Director/Board Member | 79 | 2024-05-05 |
Erick Lucera
BRD | Director/Board Member | 58 | 2023-04-02 |
David Link
BRD | Director/Board Member | 70 | 2021-10-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/24/26 | Tax | Chief Technology Officer | 988 | 0.0021% | ||
| 2/5/26 | Free | Chief Executive Officer | 4,800,000 | 10.0826% | ||
| 2/3/26 | Free | Chief Technology Officer | 2,400,000 | 5.0413% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | -5.67% | +72.64% | -46.96% | 337M | |
| +1.03% | -3.11% | +39.80% | +94.60% | 68.21B | |
| +1.62% | +0.33% | +48.61% | +89.64% | 64.25B | |
| +2.13% | -0.21% | -14.57% | +370.72% | 26.54B | |
| +1.60% | -8.03% | +2.88% | -15.15% | 25.61B | |
| +1.30% | +0.74% | +31.66% | -18.33% | 19.88B | |
| -0.38% | -12.42% | +224.86% | +373.18% | 17.13B | |
| +0.65% | -5.83% | +1.44% | +544.44% | 14.93B | |
| +2.32% | +3.60% | +56.32% | +160.98% | 14.1B | |
| +0.81% | +0.72% | +24.46% | +194.18% | 12.45B | |
| Average | +1.01% | -3.66% | +48.81% | +174.73% | 26.34B | |
| Weighted average by Cap. | +1.30% | -3.01% | +42.33% | +153.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 62.5K 53.92K 50.79K 46.28K 86.5K 5.9M 87.15K 601K 233K 3.02M 235K 230K 9.92M |
| Net income | -85.34M -73.62M -69.35M -63.19M -118M -8.06B -119M -821M -319M -4.12B -320M -313M -13.54B | -102M -87.59M -82.51M -75.17M -141M -9.59B -142M -977M -379M -4.9B -381M -373M -16.11B |
| Net Debt | -255M -220M -207M -189M -353M -24.06B -355M -2.45B -951M -12.3B -957M -936M -40.41B | -277M -239M -225M -205M -383M -26.15B -386M -2.66B -1.03B -13.37B -1.04B -1.02B -43.91B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | US$3.660 | -1.08% | 174,483 |
| 26-09-01 | US$3.700 | -0.27% | 202,282 |
| 26-08-31 | US$3.710 | -2.11% | 201,144 |
| 26-08-28 | US$3.790 | -3.56% | 202,596 |
| 26-08-27 | US$3.930 | +1.29% | 282,217 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SABS Stock
Select your edition
All financial news and data tailored to specific country editions
